Objectives

After participating in this educational activity, attendees should be able to:

1|Describe the genetics and symptoms of Huntington’s Disease
2|Discuss of treatments currently available and under development 
3|Recognize the importance of a multidisciplinary team and will learn strategies on how to implement a multidisciplinary team model in their own practice

 

Presenter(s): 
Dr. Shakaib Khan M.D.
University of Connecticut Health Center
263 Farmington Ave, Farmington, Ct 06032
 

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Dr. Shakaib Khan M.D.SpeakerNo relevant relationships with ineligible companies to discloseAntipsychotics for treatment of movements in HD
Session date: 
02/04/2026 - 9:00am to 10:00am EST
Location: 
Zoom & In Person at Baystate Medical Center Lundy Board Room located in the Wesson Building
759 Chestnut Street
Springfield, MA 01199
United States
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 IPCE Credit Hour(s)
Please login or register to take this course.